Blood biomarkers for detecting brain injury in COVID-19 patients

(Mary Ann Liebert, Inc./Genetic Engineering News) COVID-19 can directly cause neurologic symptoms and long-term neurological disease. Elevations of blood biomarkers indicative of brain injury have been reported in the blood and cerebrospinal fluid of COVID-19 patients. Clinical application of blood biomarkers to improve medical management of COVID-19 patients